🇺🇸 FDA
Patent

US 11111375

Compositions and methods for generating oligodendrocyte precursors

granted A61KA61K35/28

Quick answer

US patent 11111375 (Compositions and methods for generating oligodendrocyte precursors) held by The Regents of the University of California expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/28